Patents by Inventor Fuminari Uehara

Fuminari Uehara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230337532
    Abstract: A triazine compound represented by formula (1) is provided. In the formula (1), A and B each independently represent an aryl group having 6 to 20 carbon atoms; L represents a phenyl group or a naphthyl group; n is 0 or 1; and C represents any one of groups X, Y, and Z below, wherein Ar1 and Ar2 each independently represent an aromatic hydrocarbon group or a pyridyl group.
    Type: Application
    Filed: October 1, 2021
    Publication date: October 19, 2023
    Applicant: TOSOH CORPORATION
    Inventors: Youhei ONO, Kana OIKE, Fuminari UEHARA, Kazuki HATTORI, Yasuhiro TAKAHASHI, Tomohiro SHONO, Naoki UCHIDA
  • Publication number: 20220274952
    Abstract: An object of the present invention is to provide a cyclic azine compound exhibiting both excellent driving voltage characteristics and excellent current efficiency characteristics. The desired cyclic azine compound has a specific structure represented by formula (1).
    Type: Application
    Filed: July 22, 2020
    Publication date: September 1, 2022
    Applicants: TOSOH CORPORATION, SAGAMI CHEMICAL RESEARCH INSTITUTE
    Inventors: Naoki UCHIDA, Hidenori AIHARA, Takuya YAMAGATA, Naoki HAYAKAWA, Natsumi NAKAJIMA, Kazuki HATTORI, Fuminari UEHARA, Yohei ONO, Masaya HIRANO, Yuta MORINAKA, Keisuke NOMURA, Eriko OHTA, Tomohiro SHONO, Kana OIKE, Kazushi HAYASHI, Keiya AOYAGI, Kosuke SATO, Toshiki NISHIURA
  • Patent number: 9539290
    Abstract: An individualized bacterial treatment of cancer is provided. The treatment includes a strain of bacteria modified by in-vivo passage through tumor grafts in experimental animals, where the modified strain exhibits enhanced cancer cell-targeting of a specific malignancy arising in a unique individual to the corresponding parent strain of bacteria. The treatment uses this modified strain for the treatment human solid-tumor malignancies by inoculating an individual with a quantity of the strain; and repeating inoculations at periodic intervals where repeated inoculations tend to progressively eliminate the solid tumor malignancy in the individual.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: January 10, 2017
    Assignee: AntiCancer Inc.
    Inventors: Ming Zhao, Fuminari Uehara
  • Publication number: 20160184369
    Abstract: An individualized bacterial treatment of cancer is provided. The treatment includes a strain of bacteria modified by in-vivo passage through tumor grafts in experimental animals, where the modified strain exhibits enhanced cancer cell-targeting of a specific malignancy arising in a unique individual to the corresponding parent strain of bacteria. The treatment uses this modified strain for the treatment human solid-tumor malignancies by inoculating an individual with a quantity of the strain; and repeating inoculations at periodic intervals where repeated inoculations tend to progressively eliminate the solid tumor malignancy in the individual.
    Type: Application
    Filed: March 3, 2016
    Publication date: June 30, 2016
    Inventors: Ming Zhao, Fuminari Uehara
  • Publication number: 20140178341
    Abstract: An individualized bacterial treatment of cancer is provided. The treatment includes a strain of bacteria modified by in-vivo passage through tumor grafts in experimental animals, where the modified strain exhibits enhanced cancer cell-targeting of a specific malignancy arising in a unique individual to the corresponding parent strain of bacteria. The treatment uses this modified strain for the treatment human solid-tumor malignancies by inoculating an individual with a quantity of the strain; and repeating inoculations at periodic intervals where repeated inoculations tend to progressively eliminate the solid tumor malignancy in the individual.
    Type: Application
    Filed: December 24, 2013
    Publication date: June 26, 2014
    Applicant: ANTICANCER, INC.
    Inventors: Ming Zhao, Fuminari Uehara